The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–251 of 251
Effects of Hepatic Triglyceride Content on Myocardial Metabolism in Type 2 Diabetes
Rijzewijk, L. J., Jonker, J. T., van der Meer, R. W., Lubberink, M., de Jong, H. W. A. M., Romijn, J. A., Bax, J. J., Roos, A., Heine, R. J., Twisk, J. W. R., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.049 · Cited by 127
Mechanisms and clinical implications of hepatocyte lipoapoptosis
Cazanave, S. C., & Gores, G. J. (2010) · Clinical Lipidology · doi:10.2217/clp.09.85 · Cited by 126
New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD)
Ali, R., & Cusi, K. J. (2009) · Annals of Medicine · doi:10.1080/07853890802552437 · Cited by 122
Self-citationFatty acids in the portal vein of the rat regulate hepatic insulin clearance.
Svedberg, J., Strömblad, G., Wirth, A. G., Smith, U., & Björntorp, P. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115534 · Cited by 121
Zhang, X., Xu, A., Chung, S. K., Cresser, J., Sweeney, G., Wong, R. L. C., Lin, A., & Lam, K. S. L. (2011) · Diabetes · doi:10.2337/db10-0650 · Cited by 120
Cusi, K. J., Kashyap, S., Gastaldelli, A., Bajaj, M. S., & Cersósimo, E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2006 · Cited by 119
Self-citationEfficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease
Omer, Z., Çetinkalp, Ş., Akyıldız, M., Yılmaz, F., Batur, Y., Yılmaz, C., & Akarca, U. S. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832e2baf · Cited by 118
Pioglitazone in the treatment of NASH: the role of adiponectin
Gastaldelli, A., Harrison, S. A., Belfort‐Aguiar, R., Hardies, J., Balas, B., Schenker, S., & Cusi, K. J. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04405.x · Cited by 115
Self-citationDissociation betweenAPOC3variants, hepatic triglyceride content and insulin resistance
Kozlitina, J., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2010) · Hepatology · doi:10.1002/hep.24072 · Cited by 114
Baranova, A. V., Gowder, S., Schlauch, K. A., Elariny, H. A., Collantes, R. S., Afendy, A., Ong, J. P., Goodman, Z. D., Chandhoke, V., & Younossi, Z. M. (2006) · Obesity Surgery · doi:10.1381/096089206778392149 · Cited by 111
Obesity - United States, 1988-2008.
Freedman, D. S. (2011) · PubMed · Cited by 109
Lifestyle intervention in individuals with normal versus impaired glucose tolerance
Schäfer, S., Kantartzis, K., Machann, J., Venter, C., Niess, A. M., Schick, F., Machicao, F. E., Häring, H.-U., Fritsche, A., & Stefan, N. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01820.x · Cited by 108
Exenatide in the treatment of diabetic patients with non-alcoholic steatohepatitis: A case series
Kenny, P. R., Brady, D. E., Torres, D. M., Ragozzino, L., Chalasani, N., & Harrison, S. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.363 · Cited by 106
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan
Okanoue, T., Umemura, A., Yasui, K., & Itoh, Y. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06547.x · Cited by 104
Kashyap, S. R., Belfort, R., Berria, R., Suraamornkul, S., Pratipranawatr, T., Finlayson, J., Barrentine, A., Bajaj, M., Mandarino, L., DeFronzo, R., et al. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00541.2003 · Cited by 103
Self-citationLee, T., Mak, K. M., Rackovsky, O., Lin, Y., Kwong, A. J., Loke, J. C., & Friedman, S. L. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22063 · Cited by 102
Watson, M., Coghlan, M. P., & Hundal, H. S. (2008) · Biochemical Journal · doi:10.1042/bj20081149 · Cited by 95
Wong, V. W., Hui, A., Tsang, S. W., Chan, J. L.-Y., Wong, G. L., Chan, A. W. H., So, W., CHENG, A. Y. S., Tong, P. C. Y., Chan, F. K. L., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03112.x · Cited by 92
Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis
Lomonaco, R., Ortiz‐Lopez, C., Orsak, B., Finch, J., Webb, A., Bril, F., Louden, C., Tio, F. O., & Cusi, K. J. (2011) · Hepatology · doi:10.1002/hep.24483 · Cited by 86
Self-citationGenetic and Environmental Susceptibility to Non-Alcoholic Fatty Liver Disease
Day, C. P. (2010) · Digestive Diseases · doi:10.1159/000282098 · Cited by 85
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83
Zib, I., Jacob, A. N., Lingvay, I., Salinas, K., McGavock, J., Raskin, P., & Szczepaniak, L. S. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.00003 · Cited by 80
Histological Findings in the Liver Before and After Gastric Bypass
Csendes, A., Smok, G., & Burgos, A. (2006) · Obesity Surgery · doi:10.1381/096089206776944904 · Cited by 78
Hepatic fatty acid partitioning
Hodson, L., & Frayn, K. N. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283462e16 · Cited by 77
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis†
Caldwell, S. H., de Freitas, L. A. R., Park, S. H., Moreno, M. L. V., Redick, J. A., Davis, C. A., Sisson, B. J., Patrie, J. T., Cotrim, H. P., Argo, C. K., et al. (2009) · Hepatology · doi:10.1002/hep.22851 · Cited by 76
Ratziu, V., Caldwell, S. H., & Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.24042 · Cited by 76
Manchanayake, J., Chitturi, S., Nolan, C. J., & Farrell, G. C. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06528.x · Cited by 73
The Medical Care Costs of Obesity: An Instrumental Variables Approach
Cawley, J., & Meyerhoefer, C. D. (2010) · National Bureau of Economic Research · doi:10.3386/w16467 · Cited by 73
Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma
Siddique, A., & Kowdley, K. V. (2011) · Clinics in Liver Disease · doi:10.1016/j.cld.2011.03.007 · Cited by 71
(How) Can We Prevent Type 2 Diabetes?
Buchanan, T. A. (2007) · Diabetes · doi:10.2337/db07-0140 · Cited by 62
Adiponectin Regulation of Stellate Cell Activation via PPARγ-Dependent and -Independent Mechanisms
Shafiei, M. S., Shetty, S., Scherer, P. E., & Rockey, D. C. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.02.035 · Cited by 61
Balent, B., Goswami, G., Goodloe, G. W., Rogatsky, E., RAUTA, O., NEZAMI, R., Mints, L., Angeletti, R. H., & Stein, D. T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04313.x · Cited by 61
Unmet Needs in Hispanic/Latino Patients with Type 2 Diabetes Mellitus
Cusi, K. J., & Ocampo, G. L. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.017 · Cited by 59
Self-citationThe Role of Non-Alcoholic Fatty Liver Disease in Cardiovascular Disease
Perseghin, G. (2010) · Digestive Diseases · doi:10.1159/000282088 · Cited by 57
Uto, H., Nakanishi, C., Ido, A., Hasuike, S., Kusumoto, K., Hirohiko, A. B. E., Numata, M., NAGATA, K., Hayashi, K., & Tsubouchi, H. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.05.008 · Cited by 57
Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
Rombouts, K., & Marra, F. (2010) · Digestive Diseases · doi:10.1159/000282094 · Cited by 56
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non‐alcoholic fatty liver disease
Hyysalo, J., Stojkovic, I., Kotronen, A., Hakkarainen, A., Sevastianova, K., Makkonen, J., Lundbom, N. M. I., Rissanen, A., Krauss, R. M., Melander, O., et al. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07045.x · Cited by 55
Wang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55
Self-citationEffect of insulin–metformin combination on hepatic steatosis in patients with type 2 diabetes
Lingvay, I., Raskin, P., & Szczepaniak, L. S. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2007.02.005 · Cited by 55
Effects of PPARg agonist pioglitazone on rat hepatic fibrosis
Yuan, G., Zhang, M., & Gong, Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i7.1047 · Cited by 53
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Chen, Y., Chen, Y., Zhao, L., Chen, Y., Mei, M., Li, Q., Ailong, H., Varghese, Z., Moorhead, J. F., & Ruan, X. Z. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06986.x · Cited by 50
A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content
Browning, J. D., Davis, J., Saboorian, H. M., & Burgess, S. C. (2006) · Hepatology · doi:10.1002/hep.21264 · Cited by 46
Effect of Weight Loss on Nonalcoholic Fatty Liver Disease
Patel, A. A., Torres, D. M., & Harrison, S. A. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181b57475 · Cited by 45
Kimura, Y., Hyogo, H., Ishitobi, T., Nabeshima, Y., Arihiro, K., & Chayama, K. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06567.x · Cited by 43
Diabetes Care: Change Is Constant
Cefalu, W. T. (2011) · Diabetes Care · doi:10.2337/dc11-2039 · Cited by 35
Lessons learned from studying families genetically predisposed to type 2 diabetes mellitus
Cusi, K. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0033-6 · Cited by 26
Self-citationKashyap, S. R., Belfort, R., Cersósimo, E., Lee, S., & Cusi, K. J. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00013.x · Cited by 22
Self-citationEnomoto, N., Takei, Y., Yamashima, S., Ikejima, K., Kitamura, T., & Sato, N. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000192394.26573.10 · Cited by 16
Can We Prevent Type 2 Diabetes
Brett, A. (2001) · Journal watch · doi:10.1056/jw200105080000005 · Cited by 15
Insulin sensitizers in nonalcoholic steatohepatitis
Harrison, S. A., Schenker, S., & Cusi, K. J. (2011) · Hepatology · doi:10.1002/hep.24179 · Cited by 4
Self-citation
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Self-citationMechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Metadata
- Authors
- Cusi, K.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 142
- Issue
- 4
- Pages
- 711-725.e6
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2074203821
- Cited by
- 911
- References
- 251
- FWCI
- 48.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.